{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:38:08Z","timestamp":1789792688439,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejphar.2026.178642","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:19:16Z","timestamp":1770164356000},"page":"178642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Decoding the immunopharmacological basis of ECT-induced clozapine level elevation: Insights from a quantitative systems pharmacology model"],"prefix":"10.1016","volume":"1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8837-299X","authenticated-orcid":false,"given":"Archana","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswa Ranjan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0663-0922","authenticated-orcid":false,"given":"Anand","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4063-9178","authenticated-orcid":false,"given":"Rituparna","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7339-1773","authenticated-orcid":false,"given":"Debasish","family":"Hota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178642_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41398-022-01960-8","article-title":"Longitudinal trajectory of response to electroconvulsive therapy associated with transient immune response & white matter alteration post-stimulation","volume":"12","author":"Andreou","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.178642_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s40263-022-00932-2","article-title":"A guideline and checklist for initiating and managing clozapine treatment in patients with treatment-resistant schizophrenia","volume":"36","author":"Correll","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2026.178642_bib3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1124\/dmd.111.038679","article-title":"Effects of interleukin-6 (IL-6) and an anti-IL-6 monoclonal antibody on drug-metabolizing enzymes in human hepatocyte culture","volume":"39","author":"Dickmann","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2026.178642_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejps.2003.09.010","article-title":"CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients","volume":"20","author":"Doude van Troostwijk","year":"2003","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2026.178642_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030532","article-title":"CYP1A2 mRNA expression rather than genetic variants indicate hepatic CYP1A2 activity","volume":"14","author":"Fekete","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178642_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113735","article-title":"Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a meta-analysis","volume":"297","author":"Gay","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2026.178642_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/164_2024_739","article-title":"Quantitative systems pharmacology development and application in neuroscience","author":"Geerts","year":"2025","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178642_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/neu.2015.8","article-title":"Combined use of clozapine and ECT: a review","volume":"27","author":"Grover","year":"2015","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.ejphar.2026.178642_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/0310057X0903700217","article-title":"An update on C-reactive protein for intensivists","volume":"37","author":"Ho","year":"2009","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.ejphar.2026.178642_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2026.178642_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainresbull.2016.11.011","article-title":"Electroconvulsive stimulation transiently enhances the permeability of the rat blood-brain barrier and induces astrocytic changes","volume":"128","author":"Ito","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2026.178642_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4306\/pi.2017.14.1.58","article-title":"Effectiveness of electroconvulsive therapy augmentation on clozapine-resistant schizophrenia","volume":"14","author":"Kim","year":"2017","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.ejphar.2026.178642_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.30773\/pi.2018.05.15","article-title":"Combination of electroconvulsive therapy and clozapine in treatment-resistant schizophrenia","volume":"15","author":"Kim","year":"2018","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.ejphar.2026.178642_bib15","first-page":"193","article-title":"ECT and Clozapine combination producing delirium : a case report","volume":"45","author":"Kumar","year":"2003","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.178642_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1017\/neu.2020.32","article-title":"Augmentation of clozapine with ECT: a retrospective case analysis","volume":"33","author":"Lally","year":"2021","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.ejphar.2026.178642_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.schres.2016.01.024","article-title":"Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: a systematic review and meta-analysis","volume":"171","author":"Lally","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2026.178642_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/npp.2010.182","article-title":"Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates","volume":"36","author":"Landau","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2026.178642_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/pgs-2018-0188","article-title":"Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective","volume":"20","author":"Legge","year":"2019","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejphar.2026.178642_bib20","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/cpt.2146","article-title":"Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva cocktail","volume":"109","author":"Lenoir","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2026.178642_bib21","first-page":"94","article-title":"A case series of clozapine titrations affected by inflammatory processes","volume":"268","author":"Leung","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2026.178642_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0253-7176.85402","article-title":"Delayed onset, protracted delirium and aspiration pneumonitis associated with a combination of clozapine and electroconvulsive therapy","volume":"33","author":"Manjunatha","year":"2011","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.ejphar.2026.178642_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115989","article-title":"Evaluation of the pharmacodynamic interaction effect of augmentation agents with clozapine in patients with treatment-resistant schizophrenia: a simulation study of clinical data","volume":"338","author":"Mishra","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2026.178642_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-199610000-00011","article-title":"Effects of clozapine on plasma cytokine and soluble cytokine receptor levels","volume":"16","author":"Pollmacher","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2026.178642_bib25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/cn400189s","article-title":"Clozapine, a fast-off-D2 antipsychotic","volume":"5","author":"Seeman","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2026.178642_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.mp.4000336","article-title":"Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors","volume":"3","author":"Seeman","year":"1998","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2026.178642_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/toxsci\/kfab154","article-title":"Clozapine induces an acute proinflammatory response that is attenuated by inhibition of inflammasome signaling: implications for idiosyncratic drug-induced agranulocytosis","volume":"186","author":"Sernoskie","year":"2022","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2026.178642_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pnpbp.2005.06.011","article-title":"Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations","volume":"30","author":"Takano","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.178642_bib29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/FPC.0000000000000347","article-title":"PharmGKB summary: clozapine pathway, pharmacokinetics","volume":"28","author":"Thorn","year":"2018","journal-title":"Pharmacogenet. Genom."},{"key":"10.1016\/j.ejphar.2026.178642_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","article-title":"Epilepsy and brain inflammation","volume":"244","author":"Vezzani","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2026.178642_bib6","series-title":"Cytochrome P450 Suppression in Human Hepatocyte Cultures by Small and Large Molecules","author":"Zhang","year":"2012"},{"key":"10.1016\/j.ejphar.2026.178642_bib31","article-title":"Clozapine induces agranulocytosis via inflammatory and hematopoietic cytokine induction of the JAK-STAT signaling pathway: evidence from network pharmacology and molecular docking","volume":"31","author":"Zhang","year":"2025","journal-title":"CNS Neurosci. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992600124X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992600124X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:08:54Z","timestamp":1772456934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992600124X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":31,"alternative-id":["S001429992600124X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178642","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding the immunopharmacological basis of ECT-induced clozapine level elevation: Insights from a quantitative systems pharmacology model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178642"}}